ArticleExperimental neurology2013

Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease.

You Me Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.